Eigen Therapeutics logo

Eigen Therapeutics Funding & Investors

Eigen Therapeutics is a biotechnology company on a mission to make therapies that make cancer easier to find and eliminate. Eigen is focused on the development of “priming” therapies, therapies that help targeted therapies reach their full potential by addressing cancer heterogeneity, making cancer cells more vulnerable and/or making healthy cells more resilient to treatment. Eigen is building a high-throughput discovery platform to explore the space of priming therapies, leveraging proprietary machine learning algorithms to discover novel associations, new classes of drugs, and new potential therapies that change a cell's state to make it more vulnerable to a targeted therapy. The Eigen platform represents the intersection of biology and engineering, and includes robotic systems, laboratory operations software, and machine learning analysis pipelines—all developed in-house—with the ultimate goal of saving more lives.

eigentx.com

Total Amount Raised: $7,000,000

Eigen Therapeutics Funding Rounds

  • Seed

    $7,000,000

    Seed Investors

    First Round Capital
    Varsha Rao
    Kevin Mahaffey
    SNR
    Alumni Ventures
    Matt De Silva
    Hawktail Management
    Builders VC
    Bioverge
    Mount Pleasant Ventures
    Milad Alucozai
    ZAKA VC
Funding info provided by Diffbot.